203 related articles for article (PubMed ID: 29752839)
1. The role of mTOR in ovarian Neoplasms, polycystic ovary syndrome, and ovarian aging.
Liu J; Wu DC; Qu LH; Liao HQ; Li MX
Clin Anat; 2018 Sep; 31(6):891-898. PubMed ID: 29752839
[TBL] [Abstract][Full Text] [Related]
2. Energy sensors and reproductive hypothalamo-pituitary ovarian axis (HPO) in female mammals: Role of mTOR (mammalian target of rapamycin), AMPK (AMP-activated protein kinase) and SIRT1 (Sirtuin 1).
Estienne A; Bongrani A; Ramé C; Kurowska P; Błaszczyk K; Rak A; Ducluzeau PH; Froment P; Dupont J
Mol Cell Endocrinol; 2021 Feb; 521():111113. PubMed ID: 33301839
[TBL] [Abstract][Full Text] [Related]
3. Defective insulin signaling and the protective effects of dimethyldiguanide during follicular development in the ovaries of polycystic ovary syndrome.
Wang F; Wang S; Zhang Z; Lin Q; Liu Y; Xiao Y; Xiao K; Wang Z
Mol Med Rep; 2017 Dec; 16(6):8164-8170. PubMed ID: 28990055
[TBL] [Abstract][Full Text] [Related]
4. Electro-acupuncture attenuates the mice premature ovarian failure via mediating PI3K/AKT/mTOR pathway.
Zhang H; Qin F; Liu A; Sun Q; Wang Q; Xie S; Lu S; Zhang D; Lu Z
Life Sci; 2019 Jan; 217():169-175. PubMed ID: 30521869
[TBL] [Abstract][Full Text] [Related]
5. The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer.
Mabuchi S; Kuroda H; Takahashi R; Sasano T
Gynecol Oncol; 2015 Apr; 137(1):173-9. PubMed ID: 25677064
[TBL] [Abstract][Full Text] [Related]
6. Akt-mTOR Signaling Mediates Abnormalities in the Proliferation and Apoptosis of Ovarian Granulosa Cells in Patients with Polycystic Ovary Syndrome.
Song WJ; Shi X; Zhang J; Chen L; Fu SX; Ding YL
Gynecol Obstet Invest; 2018; 83(2):124-132. PubMed ID: 28738378
[TBL] [Abstract][Full Text] [Related]
7. Rictor/mTORC2 pathway in oocytes regulates folliculogenesis, and its inactivation causes premature ovarian failure.
Chen Z; Kang X; Wang L; Dong H; Wang C; Xiong Z; Zhao W; Jia C; Lin J; Zhang W; Yuan W; Zhong M; Du H; Bai X
J Biol Chem; 2015 Mar; 290(10):6387-96. PubMed ID: 25564616
[TBL] [Abstract][Full Text] [Related]
8. [Involvement of PI 3 K/Akt/mTOR Signaling in Protective Effects of Moxibustion for Premature Ovarian Failure in Rats].
Zhang CR; Deng JL; Zhu WN; Miao MX; Shen WW; Cao SJ; Tang Y
Zhen Ci Yan Jiu; 2018 Feb; 43(2):75-9. PubMed ID: 29516693
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mTOR Signaling Pathway Delays Follicle Formation in Mice.
Zhang J; Liu W; Sun X; Kong F; Zhu Y; Lei Y; Su Y; Su Y; Li J
J Cell Physiol; 2017 Mar; 232(3):585-595. PubMed ID: 27301841
[TBL] [Abstract][Full Text] [Related]
10. [Effects of acupuncture on PI3K/Akt/mTOR signaling pathway in rats with premature ovarian failure].
Zhang Y; Yu B; Chen J; Zhao Z; Wang Jiali ; Huang F; Lin Y; Wang M; Zhang Y; Wei B
Zhongguo Zhen Jiu; 2015 Jan; 35(1):53-8. PubMed ID: 25906570
[TBL] [Abstract][Full Text] [Related]
11. New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators.
Sun X; Su Y; He Y; Zhang J; Liu W; Zhang H; Hou Z; Liu J; Li J
Cell Cycle; 2015; 14(5):721-31. PubMed ID: 25590233
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo.
Zhou L; Xie Y; Li S; Liang Y; Qiu Q; Lin H; Zhang Q
J Ovarian Res; 2017 Aug; 10(1):56. PubMed ID: 28814333
[TBL] [Abstract][Full Text] [Related]
13. PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer.
Li H; Zeng J; Shen K
Arch Gynecol Obstet; 2014 Dec; 290(6):1067-78. PubMed ID: 25086744
[TBL] [Abstract][Full Text] [Related]
14. PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update.
Makker A; Goel MM; Das V; Agarwal A
Gynecol Endocrinol; 2012 Mar; 28(3):175-81. PubMed ID: 21916800
[TBL] [Abstract][Full Text] [Related]
15. Restricting the induction of NGF in ovarian stroma engenders selective follicular activation through the mTOR signaling pathway.
He Y; Peng X; Wu T; Yang W; Liu W; Zhang J; Su Y; Kong F; Dou X; Li J
Cell Death Dis; 2017 May; 8(5):e2817. PubMed ID: 28542147
[TBL] [Abstract][Full Text] [Related]
16. The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells.
Lau MT; Leung PC
Cancer Lett; 2012 Dec; 326(2):191-8. PubMed ID: 22922215
[TBL] [Abstract][Full Text] [Related]
17. Placental STAT3 signaling is activated in women with polycystic ovary syndrome.
Maliqueo M; Sundström Poromaa I; Vanky E; Fornes R; Benrick A; Åkerud H; Stridsklev S; Labrie F; Jansson T; Stener-Victorin E
Hum Reprod; 2015 Mar; 30(3):692-700. PubMed ID: 25609240
[TBL] [Abstract][Full Text] [Related]
18. Kuntai capsule attenuates premature ovarian failure through the PI3K/AKT/mTOR pathway.
Zhang H; Qin F; Liu A; Sun Q; Wang Q; Li Q; Lu S; Zhang D; Lu Z
J Ethnopharmacol; 2019 Jul; 239():111885. PubMed ID: 31009706
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic target of rapamycin (MTOR) signaling during ovulation in mice.
Siddappa D; Kalaiselvanraja A; Bordignon V; Dupuis L; Gasperin BG; Roux PP; Duggavathi R
Mol Reprod Dev; 2014 Jul; 81(7):655-65. PubMed ID: 24753052
[TBL] [Abstract][Full Text] [Related]
20. The effects of melatonin on oxidative stress and prevention of primordial follicle loss via activation of mTOR pathway in the rat ovary.
Behram Kandemir Y; Aydin C; Gorgisen G
Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(2):100-106. PubMed ID: 28364790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
